HCG TRT: Can It Help Preserve Fertility and Testicular Size on Testosterone Therapy?

Disclosure: PrescribedRX sells its own treatments, so we compete with some of the companies covered here, and we may earn affiliate commissions.

MEDICAL DISCLAIMER This content is for informational purposes only and does not constitute medical advice. Consult a licensed physician before starting any hormone therapy or treatment.

You started testosterone therapy to feel like yourself again, but now you are worried about a tradeoff few people warned you about: shrinking testicles and a possible hit to your fertility. It is one of the most common concerns men raise once they begin treatment to increase testosterone, and it is a fair one. This is where an HCG TRT approach enters the conversation, because pairing testosterone with human chorionic gonadotropin (HCG) is one of the main strategies clinicians use to help protect testicular size and sperm production during therapy.

If you are weighing your options, you are not alone, and you may not have to choose between feeling better and keeping your future fertility intact. Research suggests that adding HCG on testosterone therapy may help maintain the natural signals your testes rely on, which can support their size and function while you treat your symptoms. This guide breaks down what HCG actually does, who tends to consider it, the key tradeoffs, and the questions worth raising with a provider before you decide.

Why Fertility and Testicular Size Come Up With TRT

When you take testosterone from an outside source, your body senses the higher levels in your bloodstream and assumes it no longer needs to make its own. The brain dials back the signals, luteinizing hormone (LH), and follicle stimulating hormone (FSH), that normally tell the testes to keep working. This communication system is known as the hypothalamic pituitary gonadal axis, and exogenous testosterone tends to suppress it.

Two consequences often follow from that suppression. First, the testes can shrink, since the tissue is no longer being stimulated the way it was before. Many men notice this within the first few months of therapy. Second, sperm production can fall, sometimes considerably, because the testosterone produced inside the testes, not the kind circulating in your blood, is what drives healthy sperm development. Research suggests that for some men on testosterone alone, sperm counts can drop well below their baseline range over a matter of months.

This is also why the effect of HCG on testosterone therapy is studied so closely. For a man who has finished having children, testicular changes and reduced fertility may not be a pressing concern. For a younger man, or anyone who wants to keep the door open to fatherhood, it is often the deciding factor in how treatment is structured. That gap is exactly what an HCG TRT strategy is designed to address.

How pronounced these changes are varies widely. Some men see only modest shrinkage, while others notice it more clearly, and the same is true for sperm counts. The more encouraging part is that for many men these effects are not necessarily permanent. When fertility is planned for in advance, the testes can often be kept active throughout treatment rather than allowed to go dormant and then coaxed back later. That is why the timing of the conversation, ideally before therapy begins, tends to matter as much as the specific medication involved.

What an HCG TRT Approach Actually Does

HCG, short for human chorionic gonadotropin, is a hormone that closely mimics LH, the very signal your body stops sending once testosterone therapy begins. Because it looks like LH to the testes, HCG can bind to the same receptors and prompt the testes to keep producing testosterone internally, even while the pituitary stays quiet.

In practical terms, an HCG TRT protocol works on two fronts at once. The prescribed testosterone manages your symptoms and keeps blood levels steady, while the HCG keeps the testes active by standing in for the missing LH signal. Research suggests this combination may help maintain intratesticular testosterone, the internal supply that sperm production depends on, which is why it is associated with better preservation of both testicular size and fertility compared with testosterone used on its own.

It can help to think of it this way: testosterone therapy tells the brain to stop signaling the testes, and HCG talks to the testes directly, skipping the brain entirely. That direct line is what may allow the underlying machinery to keep running during treatment. Results vary from person to person, and no approach guarantees fertility, but the mechanism is well understood and widely used in men’s health practice.

Does HCG Preserve Fertility or Restore It?

It is worth separating two related goals. Preservation means keeping the testes working from the outset so fertility is protected as you go, which is the more straightforward scenario. Restoration refers to recovering sperm production after it has already been suppressed, sometimes in men who have been on testosterone for a while without any protective measure in place. 

Research suggests HCG may have a role in both situations, though preserving function from the start is generally simpler than restarting it later. A provider can help you understand which scenario applies to you and what is realistic to expect.

How Does HCG Compare to Other Fertility-Friendly Options?

HCG is not the only tool clinicians use to protect fertility during hormone care, and understanding the alternatives can make your provider conversation more productive.

HCG works directly on the testes, mimicking the LH signal the pituitary stops sending during therapy. Because it acts further downstream than the brain, it can keep the testes stimulated even when the pituitary is heavily suppressed by outside testosterone.

Selective estrogen receptor modulators, such as enclomiphene and clomiphene, take a different route. Rather than acting on the testes, they encourage the pituitary itself to keep releasing LH and FSH, which in turn stimulate the testes. For some men, particularly those not yet on testosterone, these oral options may support the body’s own production while preserving fertility, which is why enclomiphene comes up so often in fertility-conscious care.

Gonadorelin, a synthetic version of the hormone that prompts the pituitary, is sometimes used as well, though the evidence for it as an add-on to testosterone therapy is still developing compared with HCG. Each of these approaches suits different goals, health profiles, and preferences. There is no single best answer for everyone, only the option that fits you, which is one more reason this is a decision to make with a provider rather than from a forum thread.

Key Considerations Before Combining TRT and HCG

Pairing TRT and HCG is not automatically right for every man, and the decision depends on your goals, your health history, and your provider’s judgment. A few factors tend to shape the conversation.

Your fertility timeline. Some men add HCG from the very start of therapy as a kind of insurance policy, wanting to keep their options open even if they are not trying to conceive right now. Others may not feel they need it. Where you fall on that spectrum matters, and it is worth thinking through before you begin.

Monitoring. Like testosterone itself, HCG is something a provider manages over time, with periodic lab work to see how your body is responding. Estrogen levels, red blood cell counts, and other markers are typically watched, since adding HCG can influence them.

Possible side effects. No medication is free of tradeoffs. Some men may experience side effects, and what suits one person may not suit another. This is a conversation to have with a licensed provider rather than a decision to make on your own.

Access and regulatory status. The availability and regulatory standing of HCG have shifted in recent years, which can affect how it is prescribed and where it can legitimately be sourced. A provider who works in this area regularly can explain the current landscape and what appropriate, legal options look like for your situation.

There are also alternatives worth knowing about. Some men explore medications that stimulate the body’s own hormone production through the pituitary rather than acting on the testes directly, such as enclomiphene or clomiphene. These work differently from HCG and suit different goals, which is another reason an individualized provider conversation matters. For a closer look at how testosterone therapy and reproductive health interact, our guide to TRT and fertility is a useful next read.

What to Ask Your Provider

Walking into an appointment with the right questions can make the conversation far more productive, especially if hormone care is not your provider’s main focus. Consider raising the following:

• Given my age and fertility goals, is preserving testicular function something we should plan for from the start?
• How would adding HCG fit into my overall treatment, and what would we be monitoring along the way?
• What does the current regulatory and access picture look like for HCG, and what are my legitimate options?
• If fertility is a priority, are there alternatives such as enclomiphene that might suit my situation better?
• What side effects should I watch for, and when should I reach out to you?
• How often will I need lab work, and which markers will we track over time?

A good provider will welcome these questions and walk through them patiently. If your current doctor brushes off your concerns about fertility or testicular size without discussing options, seeking input from a men’s health specialist or endocrinologist is a reasonable next step.

Practical Next Steps

If preserving fertility and testicular size matters to you, here is a sensible way to approach it without jumping to conclusions.

Get clear on your goals. Decide whether future fertility is something you want to protect, even if you are unsure about timing. That single answer shapes much of what follows.

Get tested and evaluated. A proper hormone evaluation, including the relevant lab work, gives a provider the information needed to recommend an approach that fits you. Telehealth providers can often order labs and review results, which helps if specialist access is limited. If you are still mapping out the basics of therapy itself, The Complete Guide to TRT in 2026 covers how treatment works from the ground up.

Have the fertility conversation early. It is far easier to build fertility preservation into a plan from the beginning than to course correct later. Raising it before you start, or early in treatment, tends to give you the most flexibility.

Work with a provider who knows this terrain. Hormone care is a specialty, and experience with fertility-conscious protocols varies widely. The right provider will tailor the plan to your goals rather than applying a one size fits all template.

Ready to Get Answers? Book a TRT consultation with a licensed provider through PrescribedRX. Review your labs, understand your fertility options, and decide what is right for you, on your timeline. Have questions first? Contact PrescribedRX and the team can point you in the right direction.

Taking the Next Step

Low testosterone is treatable, and wanting relief from your symptoms does not have to mean giving up on fertility or accepting changes to your body you would rather avoid. For many men, an HCG TRT approach offers a way to feel better while keeping the testes active, though whether it is right for you is a genuinely individual decision best made with a knowledgeable provider.

If you would like a structured starting point, PrescribedRX connects you with licensed providers who can review your labs, talk through your fertility goals, and build a plan that is appropriate for your situation. It is a practical way to move from wondering to a clear, personalized answer, without committing to anything before you understand your options.

Related reading

More on testosterone therapy:

• TRT and fertility — what testosterone does to sperm count.
• TRT guide
• TRT cost
• Cheapest online TRT clinics
• Online TRT clinic insurance
• Does insurance cover TRT
• How to get TRT online
• TRT near me
• Enclomiphene
• Enclomiphene side effects
• PCT after TRT
• Peptide therapy overview
• Sermorelin therapy guide

Plans from PrescribedRX

PrescribedRX prescribes through clinicians licensed in your state. Plans in this category:

• Injectable Testosterone
• Testosterone Cream
• Enclomiphene

Every plan and its current price is on the plans page and the pricing page.

About This Guide

This article was written and reviewed in accordance with our editorial standards. Information about treatment mechanisms and recovery timelines is drawn from peer-reviewed research and current clinical literature as of May 2026. Content is written and reviewed by Juan Montes, a nurse with emergency and critical care experience. This guide is for informational purposes only and is not a substitute for individualized medical advice from a qualified provider.

Regulatory Status: What hCG Is and Is Not Approved For

This page discusses an off-label use, and you should know that before reading further.

hCG has three FDA-approved indications, set out in the prescribing information for Pregnyl: prepubertal cryptorchidism, selected cases of hypogonadotropic hypogonadism in males, and ovulation induction in women. Preserving fertility or testicular size during testosterone therapy is not among them. That use is off-label, which does not make it improper (clinicians prescribe off-label routinely), but it does mean there is no FDA-approved dosing for this purpose.

There is a second point worth stating. Since 23 March 2020, hCG has been regulated as a biological product rather than a drug. The FDA’s notice to compounders confirms that products transitioning on that date are “not eligible for the exemptions for compounded drugs under sections 503A and 503B of the FD&C Act.” If you are considering compounded hCG from any provider, ask them directly how they reconcile that.

What the Evidence Actually Supports

The mechanism is well established. hCG acts on the same testicular receptor as luteinising hormone, and a controlled study showed that low-dose hCG maintained intratesticular testosterone during full gonadotropin suppression. Serum testosterone represents only about 1% of intratesticular levels, and testosterone therapy alone reduced intratesticular testosterone by 94%.

The evidence for outcomes is thinner than the mechanism suggests. The main study of hCG alongside testosterone followed 26 men, was retrospective, single-centre and had no control group. It reported that no patient became azoospermic. That is encouraging, and it is not the same as established efficacy. The AUA/ASRM guideline rates hCG for this purpose as a Conditional recommendation, Grade C evidence.

On testicular size specifically: we could not find controlled studies measuring testicular volume with hCG added to testosterone therapy. Patients report it. It is not established.

References

1. PREGNYL (chorionic gonadotropin for injection) Prescribing Information, rev. 03/2023. FDA label (PDF)
2. U.S. Food and Drug Administration. Notice to Compounders: Changes That Affect Compounding on March 23, 2020. FDA
3. Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression. J Clin Endocrinol Metab. 2005;90(5):2595–2602. PMID 15713727
4. Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647–650. PMID 23260550
5. Wenker EP, Dupree JM, Langille GM, et al. The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. J Sex Med. 2015;12(6):1334–1337. PMID 25904023
6. Hohl A, Chavez MP, Pasqualotto E, et al. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Arch Endocrinol Metab. 2025;69(5):e250093. PMID 41066380
7. American Urological Association / American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. 2020, amended 2024. AUA/ASRM Guideline (PDF)

Last reviewed against current guidance: August 2026.

Related

• Enclomiphene: what the research actually shows
• Enclomiphene side effects
• Enclomiphene vs clomiphene

This article is for general information. It is not medical advice and it is not a recommendation for any particular treatment. Whether a treatment is appropriate for you is a decision for a licensed clinician who has reviewed your health history and current medications.